Site Name:
UK - Hertfordshire - Stevenage, USA - Pennsylvania - Upper Providence Posted Date:
Jan 16 2025 GSK’s Precision Medicine group is seeking an Oncology Clinical Imaging expert to join our team. The Clinical Imaging team’s mission is to evaluate, develop and implement imaging biomarkers in clinical drug development. In this role, you will oversee the setup and delivery of imaging endpoints for Phase 1 to Phase 4 clinical trials, ensuring a complete and accurate data package is provided to study teams. At GSK, you’ll work with a team of experts dedicated to improving patient outcomes through innovative imaging solutions. You’ll have the opportunity to lead key projects, collaborate with top-tier professionals, and contribute to groundbreaking advancements in oncology. In this role you will: Serve as an in-house imaging specialist, particularly in Phase 2-3 studies with common imaging-based response assessment criteria. Integrate seamlessly with the Oncology Clinical Development study teams as RECIST 1.1 expert and perform instream imaging data review and query resolution. Provide advice and recommendations on standardisation of imaging techniques to study teams and local Clinical Operations colleagues, ensuring proper implementation and oversight of imaging in clinical trials. Network within GSK’s matrix environment to identify and meet stakeholders, and devise imaging strategies that help progress assets through the development pipeline. Evaluate and implement cutting-edge imaging techniques such as PET-CT to measure drug delivery, target binding and therapeutic response in patients. Work closely with study teams and advanced technology groups (AI/ML, Stats, Precision Medicine) to devise, implement and analyse imaging biomarkers in clinical study protocols. Build and maintain relationships with key opinion leaders, imaging consultants, imaging CROs, and academic labs to support disease-specific imaging needs. Maintain a state-of-the-art knowledge of advances in Oncology imaging and represent GSK in external meetings. Basic Qualifications & Skills: Bachelor’s degree in a biomedical or imaging-related field. Experience in clinical imaging using multiple radiological imaging modalities (e.g. CT, PET, MRI). CRO/pharma experience in drug development. Preferred Qualifications & Skills: Medical, master’s or PhD degree with imaging experience in the fields of clinical pharmacology, radiology, nuclear medicine or drug development. Understanding of cancer biology and clinical staging. Strong understanding of clinical trial design and statistics for imaging endpoints. Successful implementation of imaging strategies for biological targets or drugs. Experience in authoring scientific articles and clinical trial documents. Closing Date for Applications:
Thursday 30th January (COB) Please take a copy of the Job Description, as this will not be available post closure of the advert. When applying for this role, please use the ‘cover letter’ of the online application or your CV to describe how you meet the competencies for this role, as outlined in the job requirements above. The information that you have provided in your cover letter and CV will be used to assess your application. At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people over the next 10 years. R&D is committed to discovering and delivering transformational vaccines and medicines to prevent and change the course of disease. We are revolutionising the way we do R&D. Why GSK? GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. As an Equal Opportunity Employer, we are open to all talent. In the US, we also adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to neurodiversity, race/ethnicity, colour, national origin, religion, gender, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class. We believe in an agile working culture for all our roles. If flexibility is important to you, we encourage you to explore with our hiring team what the opportunities are.
#J-18808-Ljbffr
UK - Hertfordshire - Stevenage, USA - Pennsylvania - Upper Providence Posted Date:
Jan 16 2025 GSK’s Precision Medicine group is seeking an Oncology Clinical Imaging expert to join our team. The Clinical Imaging team’s mission is to evaluate, develop and implement imaging biomarkers in clinical drug development. In this role, you will oversee the setup and delivery of imaging endpoints for Phase 1 to Phase 4 clinical trials, ensuring a complete and accurate data package is provided to study teams. At GSK, you’ll work with a team of experts dedicated to improving patient outcomes through innovative imaging solutions. You’ll have the opportunity to lead key projects, collaborate with top-tier professionals, and contribute to groundbreaking advancements in oncology. In this role you will: Serve as an in-house imaging specialist, particularly in Phase 2-3 studies with common imaging-based response assessment criteria. Integrate seamlessly with the Oncology Clinical Development study teams as RECIST 1.1 expert and perform instream imaging data review and query resolution. Provide advice and recommendations on standardisation of imaging techniques to study teams and local Clinical Operations colleagues, ensuring proper implementation and oversight of imaging in clinical trials. Network within GSK’s matrix environment to identify and meet stakeholders, and devise imaging strategies that help progress assets through the development pipeline. Evaluate and implement cutting-edge imaging techniques such as PET-CT to measure drug delivery, target binding and therapeutic response in patients. Work closely with study teams and advanced technology groups (AI/ML, Stats, Precision Medicine) to devise, implement and analyse imaging biomarkers in clinical study protocols. Build and maintain relationships with key opinion leaders, imaging consultants, imaging CROs, and academic labs to support disease-specific imaging needs. Maintain a state-of-the-art knowledge of advances in Oncology imaging and represent GSK in external meetings. Basic Qualifications & Skills: Bachelor’s degree in a biomedical or imaging-related field. Experience in clinical imaging using multiple radiological imaging modalities (e.g. CT, PET, MRI). CRO/pharma experience in drug development. Preferred Qualifications & Skills: Medical, master’s or PhD degree with imaging experience in the fields of clinical pharmacology, radiology, nuclear medicine or drug development. Understanding of cancer biology and clinical staging. Strong understanding of clinical trial design and statistics for imaging endpoints. Successful implementation of imaging strategies for biological targets or drugs. Experience in authoring scientific articles and clinical trial documents. Closing Date for Applications:
Thursday 30th January (COB) Please take a copy of the Job Description, as this will not be available post closure of the advert. When applying for this role, please use the ‘cover letter’ of the online application or your CV to describe how you meet the competencies for this role, as outlined in the job requirements above. The information that you have provided in your cover letter and CV will be used to assess your application. At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people over the next 10 years. R&D is committed to discovering and delivering transformational vaccines and medicines to prevent and change the course of disease. We are revolutionising the way we do R&D. Why GSK? GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. As an Equal Opportunity Employer, we are open to all talent. In the US, we also adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to neurodiversity, race/ethnicity, colour, national origin, religion, gender, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class. We believe in an agile working culture for all our roles. If flexibility is important to you, we encourage you to explore with our hiring team what the opportunities are.
#J-18808-Ljbffr
